Publications

Robert W. Mahley, MD, PhDHodoglugil U, Williamson DW, Yu Y, Farrer LA, Mahley RW. Glucuronic acid epimerase is associated with plasma triglyceride and high-density lipoprotein cholesterol levels in Turks. Ann Hum Genet. 2011 May; 75(3):398-417. View in: PubMed
Robert Mahley, MD, PhDAdvancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational Summit. View in: PubMed
Lennart Mucke, MDHuang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012 Mar 16; 148(6):1204-22. View in: PubMed
Lennart Mucke, MDNeurotoxicity of Amyloid ß-Protein: Synaptic and Network Dysfunction. View in: PubMed
Jorge J. Palop, PhDEpilepsy and cognitive impairments in Alzheimer disease. View in: PubMed
Katerina Akassoglou, PhDDavalos D, Akassoglou K. In vivo imaging of the mouse spinal cord using two-photon microscopy. J Vis Exp. 2012; (59):e2760. View in: PubMed
Steve Finkbeiner, MD, PhDMethylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models. View in: PubMed
Steve Finkbeiner, MD, PhDMiller J, Arrasate M, Brooks E, Libeu CP, Legleiter J, Hatters D, Curtis J, Cheung K, Krishnan P, Mitra S, Widjaja K, Shaby BA, Lotz GP, Newhouse Y, Mitchell EJ, Osmand A, Gray M, Thulasiramin V, Saudou F, Segal M, Yang XW, Masliah E, Thompson LM, Muchowski PJ, Weisgraber KH, Finkbeiner S. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol. 2012; 8(3):318. View in: PubMed
Li Gan, PhDCX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. View in: PubMed
Li Gan, PhDCho SH, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem. 2011 Sep 16; 286(37):32713-22. View in: PubMed